Ipca Laboratories Limited
NYSE
Ipca Laboratories Limited's latest marketcap:
As of 06/06/2025, Ipca Laboratories Limited's market capitalization has reached $4.1 B. According to our data, Ipca Laboratories Limited is the 3751th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.1 B |
| Revenue (ttm) | 1.04 B |
| Net Income (ttm) | 85.98 M |
| Shares Out | 253.7 M |
| EPS (ttm) | 0.34 |
| Forward PE | 31.59 |
| Ex-Dividend Date | 08/05/2025 |
| Earnings Date | 05/27/2025 |
Ipca Laboratories Limited's yearly market capitalization.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | ₹351.63 B | -18.24% |
| 12/31/2024 | ₹430.08 B | 52.29% |
| 12/29/2023 | ₹282.41 B | 32.03% |
| 12/30/2022 | ₹213.9 B | -22.18% |
| 12/31/2021 | ₹274.86 B | -1.01% |
| 12/31/2020 | ₹277.65 B |
Company Profile
About Ipca Laboratories Limited
Ipca Laboratories Limited is a leading pharmaceutical company engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs). With a strong presence in India and global markets, the company serves therapeutic needs across multiple regions, including Europe, Africa, the Americas, Asia, CIS, and Australasia.
Key Offerings
- APIs: Specializes in anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic therapeutic areas.
- Formulations: Provides a wide range of generic and branded formulations across diverse therapeutic segments, including:
- Allergy, anti-neoplastic/cancer drugs, anti-arthritic
- Anti-epileptic, anti-hypertensive, cardiology
- Diabetes, dermatology, diabetology
- Gastroenterology, hematology, hepatoprotectives
- Infectious diseases, malaria, neurology
- Nutraceuticals, ophthalmology, orthopedics
- Psychiatry, respiratory, rheumatology, and urology
Global Reach
The company exports its high-quality pharmaceutical products worldwide, reinforcing its commitment to global healthcare.
Company Background
Founded in 1949, Ipca Laboratories is headquartered in Mumbai, India, and continues to be a trusted name in the pharmaceutical industry.
Frequently Asked Questions
-
What is Ipca Laboratories Limited's (NSE-IPCALAB) current market cap?As of 06/06/2025, Ipca Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $4.1 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Ipca Laboratories Limited (NSE-IPCALAB) rank globally by market cap?Ipca Laboratories Limited global market capitalization ranking is approximately 3751 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.